{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:57:42Z","timestamp":1792623462905,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021356","name":"The Great Pierre Lavoie Challenge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000095","name":"Savoy Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.eclinm.2024.102740","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T08:53:31Z","timestamp":1721292811000},"page":"102740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Safety and efficacy of deoxycytidine\/deoxythymidine combination therapy in POLG-related disorders: 6-month interim results of an open-label, single arm, phase 2 trial"],"prefix":"10.1016","volume":"74","author":[{"given":"Heather","family":"Pekeles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoussen","family":"Berrahmoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.T.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-1859","authenticated-orcid":false,"given":"Paula J.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Buhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-4593","authenticated-orcid":false,"given":"Kenneth A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102740_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clp.2019.10.008","article-title":"Mitochondrial DNA depletion syndromes","volume":"47","author":"Basel","year":"2020","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.eclinm.2024.102740_bib2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0883073814537380","article-title":"Defects of mitochondrial DNA replication","volume":"29","author":"Copeland","year":"2014","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib4","first-page":"1732","article-title":"Mitochondrial and metabolic myopathies","volume":"25","author":"Cohen","year":"2019","journal-title":"Continuum"},{"key":"10.1016\/j.eclinm.2024.102740_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.1976.00500030042009","article-title":"Infantile diffuse cerebral degeneration with hepatic cirrhosis","volume":"33","author":"Huttenlocher","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ana.24922","article-title":"Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency","volume":"81","author":"Lopez-Gomez","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.25506","article-title":"Deoxynucleoside therapy for thymidine kinase 2-deficient myopathy","volume":"86","author":"Dominguez-Gonzalez","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15252\/emmm.201404092","article-title":"Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency","volume":"6","author":"Garone","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.eclinm.2024.102740_bib10","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1096\/fj.201801591R","article-title":"Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts","volume":"33","author":"Bl\u00e1zquez-Bermejo","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.eclinm.2024.102740_bib11","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300650RR","article-title":"Deoxyribonucleoside treatment rescues EtBr-induced mtDNA depletion in iPSC-derived neural stem cells with POLG mutations","volume":"37","author":"Kristiansen","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.eclinm.2024.102740_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nmd.2006.08.006","article-title":"A\u00a0scale to monitor progression and treatment of mitochondrial disease in children","volume":"16","author":"Phoenix","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.eclinm.2024.102740_bib13","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: a scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.eclinm.2024.102740_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.26260","article-title":"Natural history of Leigh syndrome: a study of disease burden and progression","volume":"91","author":"Lim","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib15","article-title":"Cinical, metabolic, and genetic analysis and follow-up of eight patients with HIBCH mutations presenting with leigh\/leigh-like syndrome","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.eclinm.2024.102740_bib16","series-title":"Manual for Newcastle mitochondrial disease adult scale (NMDAS)","year":"2016"},{"key":"10.1016\/j.eclinm.2024.102740_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66940-8","article-title":"Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy","volume":"10","author":"Dominguez-Gonzalez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.eclinm.2024.102740_bib18","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1515\/cclm-2022-1236","article-title":"Improved diagnostics of purine and pyrimidine metabolism disorders using LC-MS\/MS and its clinical application","volume":"61","author":"Cremonesi","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eclinm.2024.102740_bib19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/gim.2017.35","article-title":"The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations","volume":"19","author":"Hikmat","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.eclinm.2024.102740_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/acn3.51104","article-title":"Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: a meta-analysis","volume":"7","author":"Lin","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.eclinm.2024.102740_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41588-023-01339-5","article-title":"Thymidine nucleotide metabolism controls human telomere length","volume":"55","author":"Mannherz","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.eclinm.2024.102740_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13669","article-title":"Premature aging is associated with higher levels of 8-oxoguanine and increased DNA damage in the Polg mutator mouse","volume":"21","author":"Yu","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.eclinm.2024.102740_bib23","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.3390\/ijms22126447","article-title":"Therapy prospects for mitochondrial DNA maintenance disorders","volume":"22","author":"Ram\u00f3n","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eclinm.2024.102740_bib24","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/hmg\/ddt641","article-title":"Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome","volume":"23","author":"Camara","year":"2014","journal-title":"Hum Mol Genet"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:10:41Z","timestamp":1728403841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024003195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":24,"alternative-id":["S2589537024003195"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102740","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of deoxycytidine\/deoxythymidine combination therapy in POLG-related disorders: 6-month interim results of an open-label, single arm, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102740"}}